Market
GT Medical Technologies raises $100m for brain tumour therapy advance
GT Medical Technologies secured $100 million in funding to advance its GammaTile brachytherapy system for brain tumor treatment. The company presented final Phase III clinical data comparing GammaTile against standard of care at the ASCO annual meeting, supporting the device's therapeutic profile and market positioning.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network